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Tuberculosis situation in Iraq: A puzzle of estimatesDuring the last two decades, Iraq has witnessed drastic
changes represented by 13 years of tough economic sanctions
that left their mark on the health system [1], followed by
10 years marked by struggling to recover from years of war,
sanctions, loss of health workers and political interference.
Tuberculosis (TB) detection rates during those two epochs
alternated between rise and reduction. In 2011, a total of
9,248 cases of TB were reported, giving Iraq the 8th rank
among the countries belonging to the Eastern Mediterranean
Region Organization (EMRO) with an incidence of 45/100,000
population and a prevalence of 74/100,000 population. In
addition, in 2010, the estimates of multidrug-resistant (MDR)
cases were 2.9% among new cases, and 35.8% among re-trea-
ted cases, and the estimated number of MDR cases among all
incidence cases was 820 [2]. However, looking at the TB statis-
tics during the last two decades, one can note that during the
years under sanctions, the reported detection rates were
‘‘unprecedented’’, with detection rates increased several-
times above the estimated incidence in many years [3]. This
pattern of detection rates is incomparable with other coun-
tries. The unprecedented increase in detection rates (e.g.
270%) was not explained as there was no new diagnostic facil-
ities established, no anti-TB campaigns launched, no epidem-
ics reported, and no spread of the human immunodeficiency
virus (HIV).
Accurate estimates of TB prevalence in every country are
required to monitor the country’s progress towards the Mille-
nium Development Goals (MDGs) as outlined by the World
Health Organization (WHO). The ideal way to determine the
prevalence is to conduct surveys on a represented sample size
that covers all geographic regions. Owing to the current situ-
ation of Iraq, determining the real prevalence of TB is far from
reachable. All current TB statistics in Iraq and attributes of
controlling program are relying on ‘‘Estimates of Incidence’’.
Estimates of incidence are based on a consultative and ana-
lytical process led by WHO and are published annually; basi-
cally, data collected from a country (as part of the routine
surveillance under DOTS [directly observed treatment short
course]) are used in country-specific analyses to generate
the estimate. Detection rate–the most important indicator–is
calculated by dividing the number of new smear-positive
cases by the estimated number of incident smear-positive
cases for the same year and represented in a percentage.
There are reasons to believe that the data obtained and con-
sequently the estimates of incidence in Iraq are not accurate.Iraq adopted the DOTS strategy in April 1998 and 100%
coverage is assumed to have been achieved in the early
2000s [4]. The National Tuberculosis Programme (NTP-Iraq)
promoted by the Ministry of Health (MOH) and WHO is
responsible for drug procurement, distribution of national
TB guidelines, training of TB managers and staff, improving
the quality of smear microscopy, collaboration with other
health sectors and NGOs, in addition to the assessment and
evaluation of the Programme’s progress. District TB Coordina-
tor (DTC) units are distributed throughout the country and
responsible for monitoring patient treatment in the Primary
Health Care Centre (PHCC). Indeed, besides the staff short-
ages, many laboratories participating in DOTS programs have
insufficient equipment and supplies, and limited procedures
for quality assurance. The National Reference Laboratory
(NRL) is the only accredited laboratory across Iraq performing
laboratory culturing and identification of MDR cases. Patients
suspected to be MDR cases (treatment failure, relapsed, or
after default) are referred from throughout Iraq to the NRL.
The method used for testing drug susceptibility in the NRL
is phenotypic drug susceptibility testing (DST) using the
time-consuming indirect proportion method on Lowenstein-
Jensen (ILJ) medium. The wide use of this method in other
places is hindered by the lack of laboratories equipped to per-
form this method. After receiving accreditation in 2011, the
NRL started to provide reliable results about the MDR cases,
and community-based treatment with second-line anti-
tuberculosis drugs was launched for the first time inside Iraq.
In addition, there is discrepancy between TB data released
by NTP-Iraq and other authorities and/or officials. For
instance, NTP-Iraq mentioned that 8,258 TB cases were
reported in 2003, whereas the Minister of Health at that time
mentioned a different number: 11,656 cases. Other data dis-
crepancies could be noted in estimates of TB prevalence; for
instance, for the years 2009–2010, the World Bank recorded a
prevalence of 74/100,000 [5], whereas WHO demonstrated 56/
100,000 [6]. Huge discrepancies could be seen in detection rates
mentioned in published articles and that released by WHO or
the World Bank; in spite of that, authors of those papers are
affiliated with the WHO-Iraq unit. For example, according to
a study done by one of the authorized persons in NTP-Iraq
and aimed at an ‘‘evaluation of the DOTS strategy for 5 years,’’
the detection rates for the years 2000 to 2005 were 20–23% [4];
however, the World Bank and WHO expressed very much
higher detection rates for the same period (range 72–95%) [5].
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gent survey to figure out the real picture of tuberculosis in
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